Healthcare
Live Price
Offline$15.82
+2.33% today
1Y Change
+39.40%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sotera Health Company (SHC) is a Healthcare stock with a market cap of $4.42B and listed on NASDAQ. The stock last traded around $15.82 and up 39.4% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +5.7%, EPS growth of +68.8%, a dividend yield of 0.0%. What stands out right now is revenue +5.7%, EPS +68.8%, free cash flow +230.8% with operating margin 33.8% and ROIC 6.8%. Valuation already assumes a fairly strong business story at P/E 56.5 and price/sales 3.8. Stock Foundry combines SHC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SHC Max Drawdown
-32.14%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SHC and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$931.5M
-7.2% YoY
FY Net Income
$116.9M
+150.0% YoY
Free Cash Flow
$179.4M
+87.7% YoY
Revenue Growth
+5.7%
EPS Growth
+68.8%
Gross Margin
55.5%
Net Margin
6.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.0B | 1.0B | 931M |
| Gross Profit | 646M | 602M | 577M | 557M | 519M |
| Operating Income | 393M | 298M | 277M | 248M | 257M |
| EBITDA | 303M | 442M | 407M | -17M | 401M |
| Net Income | 78M | 44M | 51M | -234M | 117M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 346M | 277M | 296M | 395M | 107M |
| Total Assets | 3.3B | 3.1B | 3.1B | 3.1B | 2.8B |
| Total Liabilities | 2.7B | 2.7B | 2.7B | 2.8B | 2.2B |
| Shareholder Equity | 606M | 405M | 444M | 350M | 586M |
| Total Debt | 2.3B | 2.4B | 2.3B | 2.0B | 1.8B |
| Net Debt | 1.9B | 2.1B | 2.0B | 1.6B | 1.7B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
282M
+1.3% YoY
Capital Expenditures
102M
+44.0% YoY
Free Cash Flow
179M
+87.7% YoY
Key ratios
Gross Margin
55.5%
Operating Margin
33.8%
Net Margin
6.7%
ROE
15.0%
Debt / Equity
3.75x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.